myristic acid has been researched along with Kahler Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Funakoshi, T; Kida, Y; Kubota, Y; Shoji, S; Takenaka, O; Yoshinaga, T | 1 |
1 other study(ies) available for myristic acid and Kahler Disease
Article | Year |
---|---|
Myristoylated src-oncogene products are potently detected by the monoclonal antibody to the NH2-terminal myristoyl-Gly-Ser-Ser-Lys src-peptide.
Topics: Adenocarcinoma; Amino Acid Sequence; Antibodies, Monoclonal; Antibody Specificity; Blotting, Western; Colonic Neoplasms; Humans; Molecular Sequence Data; Multiple Myeloma; Myristic Acid; Myristic Acids; Oligopeptides; Oncogene Protein pp60(v-src); Pancreatic Neoplasms; Peptides; Precipitin Tests; Tumor Cells, Cultured | 1990 |